Correlation Between Cytek Biosciences and Neogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Neogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Neogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytek Biosciences and Neogen, you can compare the effects of market volatilities on Cytek Biosciences and Neogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Neogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Neogen.

Diversification Opportunities for Cytek Biosciences and Neogen

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cytek and Neogen is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Neogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neogen and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Neogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neogen has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Neogen go up and down completely randomly.

Pair Corralation between Cytek Biosciences and Neogen

Given the investment horizon of 90 days Cytek Biosciences is expected to generate 1.09 times more return on investment than Neogen. However, Cytek Biosciences is 1.09 times more volatile than Neogen. It trades about 0.18 of its potential returns per unit of risk. Neogen is currently generating about -0.04 per unit of risk. If you would invest  268.00  in Cytek Biosciences on May 15, 2025 and sell it today you would earn a total of  149.00  from holding Cytek Biosciences or generate 55.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cytek Biosciences  vs.  Neogen

 Performance 
       Timeline  
Cytek Biosciences 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward-looking signals, Cytek Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.
Neogen 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Neogen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Cytek Biosciences and Neogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytek Biosciences and Neogen

The main advantage of trading using opposite Cytek Biosciences and Neogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Neogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neogen will offset losses from the drop in Neogen's long position.
The idea behind Cytek Biosciences and Neogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements